Hu DD - Search Results

1

A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma.

Liao LE, Hu DD, Zheng Y. Liao LE, et al. Among authors: hu dd. Genes (Basel). 2020 Aug 8;11(8):908. doi: 10.3390/genes11080908. Genes (Basel). 2020. PMID: 32784402 Free PMC article.

2

Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study.

He W, Liao L, Hu D, Li B, Wang C, Qiu J, Liao Y, Liu W, Yang Z, Zhang Y, Yuan Y, Li K, Yuan Y, Zheng Y. He W, et al. Ann Transl Med. 2020 Aug;8(16):1000. doi: 10.21037/atm-20-5298. Ann Transl Med. 2020. PMID: 32953800 Free PMC article.

3

Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.

Yuan Z, Li B, Liao W, Kang D, Deng X, Tang H, Xie J, Hu D, Chen A. Yuan Z, et al. Front Immunol. 2024 Apr 18;15:1382520. doi: 10.3389/fimmu.2024.1382520. eCollection 2024. Front Immunol. 2024. PMID: 38698857 Free PMC article.

4

The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab.

Wu W, Yang Z, Zou H, Long T, Zhou Z, Zhang Y, Chen M, Hu D. Wu W, et al. Front Immunol. 2024 Nov 1;15:1474456. doi: 10.3389/fimmu.2024.1474456. eCollection 2024. Front Immunol. 2024. PMID: 39555053 Free PMC article.

5

Risk of hepatitis B virus reactivation and its effect on survival in advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy and lenvatinib plus programmed death receptor-1 inhibitors.

Yang Z, Guan R, Fu Y, Hu D, Zhou Z, Chen M, Zhang Y. Yang Z, et al. Front Cell Infect Microbiol. 2024 Feb 13;14:1336619. doi: 10.3389/fcimb.2024.1336619. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38415009 Free PMC article.

6

Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study.

Yang Z, Wu W, Hu Z, Fu Y, Hu Z, Pan Y, Wang J, Chen J, Zhou Z, Zhang Y, Chen M, Hu D. Yang Z, et al. Front Immunol. 2024 Nov 29;15:1494520. doi: 10.3389/fimmu.2024.1494520. eCollection 2024. Front Immunol. 2024. PMID: 39676872 Free PMC article.

7

Simultaneous measurement of the antibody responses against SARS-CoV-2 and its multiple variants by a phage display mediated immuno-multiplex quantitative PCR-based assay.

Chen H, Li S, Wang J, He S, Wang D, Qian Z, Hu D, Qi F, Hu K, Luo C, Wang J. Chen H, et al. Front Microbiol. 2022 Aug 22;13:968036. doi: 10.3389/fmicb.2022.968036. eCollection 2022. Front Microbiol. 2022. PMID: 36071962 Free PMC article.

8

Melatonin ameliorates necrotizing enterocolitis by preventing Th17/Treg imbalance through activation of the AMPK/SIRT1 pathway.

Ma F, Hao H, Gao X, Cai Y, Zhou J, Liang P, Lv J, He Q, Shi C, Hu D, Chen B, Zhu L, Xiao X, Li S. Ma F, et al. Theranostics. 2020 Jun 19;10(17):7730-7746. doi: 10.7150/thno.45862. eCollection 2020. Theranostics. 2020. PMID: 32685016 Free PMC article.

9

Influenza vaccine combined with moderate-dose PD1 blockade reduces amyloid-β accumulation and improves cognition in APP/PS1 mice.

Xing Z, Zuo Z, Hu D, Zheng X, Wang X, Yuan L, Zhou L, Qi F, Yao Z. Xing Z, et al. Brain Behav Immun. 2021 Jan;91:128-141. doi: 10.1016/j.bbi.2020.09.015. Epub 2020 Sep 19. Brain Behav Immun. 2021. PMID: 32956831

10

PARP10 is highly expressed and associated with inferior outcomes in acute myeloid leukemia.

Wang L, Jiang C, Hu D. Wang L, et al. Aging (Albany NY). 2023 Jul 27;15(14):6757-6773. doi: 10.18632/aging.204832. Epub 2023 Jul 27. Aging (Albany NY). 2023. PMID: 37506247 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters